Skip to main content
. 2013 Jun 7;104(8):996–1001. doi: 10.1111/cas.12192

Figure 2.

Figure 2

Prognostic impact of CD20 on treatment‐free survival (TFS) in patients with chronic lymphocytic leukemia. Those patients whose percentage of CD20 antigen was above 60.3% had a better TFS (hazard ratio [HR], 0.452; 95% confidence interval [CI], 0.232–0.884, = 0.020).